Draft Electricity and Gas (Energy Company Obligation) (amendment) Order 2017

Ian Murray Excerpts

Wednesday 22nd March 2017 General Committees

[Jesse Norman]

I am very grateful to my hon. Friend for that intervention, and I congratulate him on making it when my remarks have barely started, such is his eagerness. The Department of course scrutinises the cost of legislation, and the order is designed to allow a transition period precisely to set the suppliers up for the next supplier obligation, which will be introduced in 2018. That should allow time for any costs associated with the changes to be absorbed within the system.

The order will also make an important contribution to the Government’s clean growth plan and to reducing carbon emissions. We are making amendments to the existing Electricity and Gas (Energy Company Obligation) Order 2014, which covers the period from 1 April 2015 to 31 March 2017. The amendments extend the current scheme from 1 April 2017 to 30 September 2018 to enable reforms to be introduced while also allowing the industry time before further improvements are made through a new longer term scheme that will run from 2018 to 2022. Planning ahead to 2022—beyond the life of this Parliament—reflects announcements on funding made in the 2015 spending review. The longer term confirmation of funding is designed to give greater certainty to energy suppliers, installers, local authorities and other energy stakeholders.

The Government are facing up to the enormous energy challenges our country faces over the coming years. With the overhaul of the electricity market and continued investment in renewable technologies, we are making good progress towards ensuring that the UK’s energy is secure, low carbon and affordable. Improving the energy efficiency of the UK’s homes is central to that challenge and to reducing fuel poverty. The energy company obligation scheme helps occupants to keep warm, reduce their energy bills and protect their health and wellbeing by requiring energy suppliers to reduce carbon emissions and energy costs through installing energy efficiency measures in households across Great Britain. The supply chains involved in that endeavour also provide economic benefits across the country.

Since the introduction of the ECO in 2013, the scheme has proved to be a remarkably reliable and cost-effective means of upgrading our housing stock. Altogether, more than 2 million energy efficiency measures had been installed in more than 1.6 million homes by the end of December 2016, with around 1.2 million of those measures going to 900,000 low income and vulnerable households and households in deprived areas. That is a significant investment in addressing energy efficiency and fuel poverty. Thanks to the amendment order we are introducing today, we forecast more than half a million more insulation measures and around 45,000 more heating measures will be delivered through the ECO by 2018.

[Ian Murray (Edinburgh South) (Lab)]

The Minister has mentioned fuel poverty several times. Will he say what the Government are doing to prevent fuel poverty with regard to energy companies and their double-digit price rises?

[Jesse Norman]

As the hon. Gentleman will know, the Government made clear in a debate last Thursday and in other remarks that they would bring forward a consumer Green Paper and a response to the Competition and Markets Authority. A specific response on the issues he raises will be addressed in those documents.

The order will reduce the overall spend of the scheme from £860 million a year now to £640 million a year. That has been done to constrain the impact of Government policies on all consumer bills. In making the change we have also sought to ensure that the support offered by the ECO is focused more on those in more need.

Motor Neurone Disease/Gordon Aikman

Ian Murray Excerpts

Monday 20th February 2017 Commons Chamber

[Ian Murray (Edinburgh South) (Lab)]

I am very grateful to the good offices of Mr Speaker and you, Madam Deputy Speaker, for granting time for this Adjournment debate. I want to talk about the dreadful disease that is motor neurone disease and to pay tribute to the life of Gordon Aikman.

I wish we were not having this debate, because that would mean Gordon Aikman was still with us. He sadly passed away on 2 February, aged just 31.

I want to do three things this evening: first, pay tribute in this House to Gordon Aikman and what he achieved both in his life and in his death; secondly, give more exposure to what MND is and how the disease affects those stricken by it; and, thirdly, discuss what we can all do and what the Government can do to help find a cure.

[Alberto Costa (South Leicestershire) (Con)]

I congratulate the hon. Gentleman on bringing this much needed debate to the Floor of the House. Will he join me in paying tribute to local MND associations across the United Kingdom for the invaluable support they provide? I know of the excellent work of my local Leicestershire and Rutland association, having heard at first hand from a constituent and friend of mine, Ruth Morrison, about her tragic personal experience. The support that is available is of immense value and I hope the hon. Gentleman will join me in paying tribute to the work of those associations.

[Ian Murray]

I am delighted that the hon. Gentleman was able to intervene to emphasise the good work that MND associations, including MND Scotland, do across the country. I pay tribute to him for highlighting that good work in the House and I ask him to pass on our best wishes to his constituents who are stricken by this dreadful disease.

Gordon Aikman was only 29 when he was diagnosed with MND. He was given 14 months to live but, as was usual with Gordon, his dedication and determination made sure he doubled that to 28. Gordon died leaving behind a loving husband, Joe, who is with us this evening, a doting mother, Nancy, and a devoted sister, Lorraine. He has become a twinkling star in the sky for his young niece Ailidh and young nephew Murray, who would describe Gordon as “Uncle Gordon with wheels” when he was in his wheelchair. He leaves behind friends whose lives will forever have a Gordon Aikman-shaped hole in them. All our thoughts at this time go out to everyone who knew him.

Gordon leaves a legacy that few of us will ever be able to match. Gordon was an inspiration: dedicated, intelligent, meticulous and simply a lovely person to be around. He touched the lives of everyone who had the pleasure of getting to know him and spend time with him. He was a graduate of the University of Edinburgh and a former gymnast who represented Scotland. He was working as director of research for Better Together, the campaign to keep Scotland in the UK, during the Scottish independence referendum in 2014 when he fell ill. He had gone to the doctors with recurring numbness in his hands. He was beginning to find it difficult to tie his shoelaces and button his shirts. He anticipated, as we all do, that a pack of pills and a bit of rest would do the trick. How wrong could he be?

I cannot do justice to what happened to Gordon, so I will let Gordon tell his own story in his own words, quoting from the moving Scotland on Sunday article he wrote in the week he was given the sad news. He wrote:

“I am lying on a cold hospital bed, stripped down with electrodes stuck all over my skin. A doctor quietly takes notes as pulses race through my body. After almost an hour I get back into my suit, ready for a packed day of calls and meetings.

The doctor steps out to speak to my consultant. I flick through the morning’s headlines on Twitter and quickly check my email as I wait. In my job as director of research at Better Together, I have got to be up to date. The doctor is gone some time. My appointment has already overrun. I’m irritated. He returns and says: ‘Your neurologist would like to see you at 1.15 tomorrow.’

‘Tomorrow won’t work. I have meetings. Meetings I can’t miss.’ He tilts his head to one side, holding my stare for what seems like an eternity, before stressing: ‘Your neurologist will see you tomorrow. 1.15.’ The penny starts to drop. Suddenly that conference on the economics of independence seems far less important. Fast-forward 24 hours and I am back at Edinburgh’s Western General. This time I sit opposite my consultant neurologist; a young, caring face looks back. He speaks softly, but this time the atmosphere is different. He talks slowly. He pauses. I know it isn’t good news, but nothing could prepare me for what he is about to say.

Tears form in his eyes as he explains that all the diagnostic tests point to something called Motor Neurone Disease or MND. I’m confused. ‘That doesn’t sound good,’ I respond awkwardly, thinking to myself: ‘I don’t have time for this.’ He asks what I know about MND. ‘Very little,’ is my honest answer.

‘It is a rare, progressive and debilitating disease,’ he explains, ‘that attacks the brain and spinal cord.’ I don’t believe what he is telling me. I shake my head in disbelief. ‘In time,’ he says, ‘it will lead to weakness, and muscle wasting,’ affecting how I walk, talk, eat, drink and breathe. How could this be? My symptoms seemed so innocuous. ‘Why me? Why now?’ I ask. He bites his lip, before replying candidly: ‘We just don’t know unfortunately.’ 

When I press further, he concedes: ‘There is no cure.’ I cut to the chase: ‘What is the prognosis? How long will I live?’ Hesitant, he prefixes his answer with ‘everybody is different’ and ‘it is difficult to predict’. He then wells up before admitting that we are talking ‘just a few years’. My head is a mess. I stand up, walk across to the window, run my hands through my hair and stare out into the middle distance. My mind goes blank. I don’t know what do. I’m 29 years old and I have just been given a death sentence.”

Gordon went on to write:

“When you are told you are dying you face a choice: you can wallow in self-pity, or you can make the most of what you’ve got”.

And, my goodness, Gordon certainly made the most of what he had. He married his husband Joe and travelled extensively. As we heard at the funeral and the celebration of Gordon’s life on Saturday, he travelled to New York, Boston, Amsterdam, Dublin, Stockholm, Madrid, Tenerife, Prague, Tuscany, Newquay, Paris, Cork, Munich, Orkney, Fort William and California, as well as Israel, South Africa, Switzerland, and had a trip on the Queen Mary II and a break in Iceland to see the northern lights. If I have missed any, I apologise. He also spent as much time as he could with his family and his friends.

With all of that, Gordon was determined to ensure that those who suffered from MND got the best care, the best deal and the hope of a cure in the future. Understanding lies at the root of all human endeavour. In order to defeat something, we must find out what it is first, so here is what we do know and, most importantly for tonight’s debate, what we do not know about MND.

[Chris Stephens (Glasgow South West) (SNP)]

I congratulate the hon. Gentleman on securing this debate. I agree with him that Gordon Aikman was indeed an inspiration. Does he agree that his campaigning work, particularly with the First Minister of Scotland, ensuring changes to the law around voice therapy, for example, and doubling the number of specialist nurses, was important to his campaign?

[Ian Murray]

I do agree, and I am delighted that the hon. Gentleman was able to make that point, but as the First Minister said on Saturday at the celebration of Gordon’s life, all the credit for those changes to care in Scotland goes to Gordon and his campaign. There is a need for us all now to take that campaign and make sure that the rest is delivered.

Researchers have yet to discover how or why people develop the disease. In Gordon’s case and in around 95% of diagnoses, there is no family history of the condition. MND is a fatal, rapidly progressing neurological disease that affects the brain and spinal cord. It can leave people locked in a failing body, unable to move, talk or, eventually, breathe. It kills a third of people within a year and more than 50% within two years of diagnosis. It affects up to 5,000 adults at any one time in the UK and kills six people every day in the UK.

[Mark Menzies (Fylde) (Con)]

I thank the hon. Gentleman for securing this evening’s debate. I never met Gordon, but I have been inspired by what I have found out about him in the last two weeks. We all come across constituents who will face life-changing situations, and Gordon will become the reference point. I will refer people to what he did, how he coped with adversity and how he helped to improve and change the lives of others. If I may also say in this intervention, Madam Deputy Speaker, I would urge the Minister to look at Gordon’s Fightback website and take on board some of the points that he raised, because we have much to learn from what he told us.

[Ian Murray]

I am delighted at the hon. Gentleman’s intervention; he is indeed right. Many people have drawn inspiration from Gordon’s Fightback, the way in which he dealt with the disease, the dignity with which he did so, and the fact that he spent his remaining time fighting to raise over half a million pounds for the things that he believed in, when most of us would have been lesser human beings and wallowed in self-pity or done something else. It is testament to that that we have the Secretary of State for Scotland and the Minister in the Chamber tonight listening to the debate. Hopefully, the Minister will be able to respond with some positive developments to keep Gordon’s memory alive.

Some people may experience changes in thinking and behaviour, with a proportion experiencing frontotemporal dementia, which is a rare form of dementia. This is the key thing about MND, though: it has no cure. It is that last point that drove Gordon on. He was a tireless and courageous campaigner on behalf of people living with MND, as well as their families and loved ones. He created his Gordon’s Fightback campaign, which we have heard about tonight, and his tenacious work with MND Scotland was inspirational to many and helped to raise awareness of MND across the country.

Gordon had raised over £500,000 by the time he died —more now, incidentally—but he had also put MND on the map. Do you remember the ice bucket challenge, Madam Deputy Speaker? I do not know whether you participated yourself—if not, we could maybe go into Palace Yard after this debate and relive what happened in 2014—but that was the summer campaign, where we all soaked each other with iced water in the name of MND awareness and fundraising. It was with campaigns such as these that Gordon doubled the number of—

[Madam Deputy Speaker (Mrs Eleanor Laing)]

Order. For the avoidance of doubt, I am glad that the hon. Gentleman has mentioned this. Never was there a better campaign to draw attention to something that needed attention drawn to it. Although I managed to avoid it myself, I did engineer other people’s participation. The hon. Gentleman has done very well to mention this issue today. I had not realised that the two things were connected. What an absolutely brilliant campaign.

[Ian Murray]

I am delighted, Madam Deputy Speaker, that you are now able to make the connection between that campaign and Gordon’s Fightback, and are aware of the significant amount of money that was raised in 2014. I do not think there was ever an end-point to the ice bucket challenge. If there was an end-point, perhaps someone from MND Scotland could let me know. I think the way it went was that if someone was soaked, they nominated others, as indeed you have done, Madam Deputy Speaker. With the grace of the House, therefore, I would like to nominate Madam Deputy Speaker to do the bucket challenge. I think the terminology is, Madam Deputy Speaker, “You have seven days”.

That, then, was the summer campaign when we all soaked each other with iced water in the name of MND awareness and fundraising. It was through campaigns such as these that Gordon doubled the number of specialist nurses in Scotland, paid for by the NHS rather than by charitable donations. Among Gordon’s more recent achievements was ensuring that MND patients with communication difficulties had access to their own voice synthesizers on the NHS. It was Gordon’s biggest fear—not just losing his own voice, but the synthesisation of his own voice being someone else’s. He fought for that and got it changed.

Despite those and other improvements, however, there is still much more to be done in the battle to defeat MND. First and foremost, if we are to find a cure for MND, we must vastly improve our understanding of its root causes, and it is here that I hope the Minister can help us this evening. MND is a question to which we have yet to find a suitable answer. Researchers still do not know what causes the disease. A key recommendation of Gordon’s Fightback campaign is to double public investment in MND research from its current level of £5 million a year to £10 million a year. Unlike some of Gordon’s wonderful achievements that we have highlighted this evening, there has to date been no action taken to meet that goal. At present, MND research relies heavily on the support and contributions of the voluntary sector.

The MND Association, sister associations in England and Wales and MND Scotland have a research portfolio comprising over 80 projects, totalling over £14 million of charitable funds, including £5 million raised by the very ice bucket challenge in which you will participate, Madam Deputy Speaker, in the next seven days. I am conscious, Madam Deputy Speaker, that this might be my last ever speech in this Chamber, but I shall carry on regardless.

The association’s support for MND research focuses on five key themes: identifying the causes of MND; developing models of MND; identifying markers of disease progression; developing treatments; and improving healthcare and disease management for those affected.

We have a real opportunity to embrace the leading research base in this country to do just that. For centuries, major leaps forward in medicine and science have been made in the UK. With the right investment and support, we could find a cure for MND here now. Scotland is uniquely placed to become a hub for innovative research into the disease for a number of reasons. Edinburgh University’s Euan MacDonald centre is already undertaking cutting-edge research into MND. Patients already have a unique patient identifier, which means those with MND can be more easily identified and monitored throughout their interaction with the health service. The increased number of specialist MND nurses will allow better, more detailed tracking of how the disease progresses in patients.

Progress has been made. The Euan MacDonald centre thinks it might have found a potential reason why motor neurons are vulnerable to stress and disease, which could be one of the very first steps to avoiding or halting the progression of MND. This collaborative project, involving the universities of Edinburgh and Cambridge and institutions as far afield as Japan, is also helping understand how motor neurons develop and regenerate. The cure could be in this generation’s hands. Funding in the United States—where the ALS Association, the US equivalent of the MND Association, has identified a key genome with funds raised by the US bucket challenge—could be the first step towards a cure.

As well as doubling public research funding, the Minister could help by making “fast-track” benefits fit for purpose. People with MND do not live long—we know that—but it can take several months to process applications for the benefits that they need, such as personal independence payments. Currently, the “fast-track” system applies only to people who are judged to have less than six months to live. That needs to be extended to 12 months, or, indeed, the system should apply at the time of diagnosis.

The hon. Member for Dumfries and Galloway (Richard Arkless) hoped to attend the debate, but he is stuck on a train somewhere between Wigan and London, and the main business ended early today. Let me just mention that his mother and brother-in-law both died of MND. I believe that he met the Under-Secretary of State for Health, the hon. Member for Warrington South (David Mowat), just before Christmas, with the aim of ensuring that when a DWP assessment was completed for someone suffering from MND, that person would not be reassessed. However, I understand from the hon. Gentleman that the Department for Work and Pensions is still issuing letters about reassessment. I should be grateful if the Minister wrote to the hon. Gentleman, and me, to update us on what progress has been made in relation to not issuing such letters when people have been diagnosed with MND and a proper assessment has already been carried out.

Let me also pay a brief tribute to another friend of mine who died from MND. Robert Wilson died in August last year. He was a former partner at Deloitte in Edinburgh, and became the first chair of the Scottish Premier League in 1998 after helping to set it up. I got to know Robert when he advised the Foundation of Hearts to be in a position to take Heart of Midlothian football club out of impending liquidation. His straight-talking style was direct. He said things as he saw them. He was always challenging, and always hugely helpful. We were lucky to have him, and so was the club. It is thanks in large part to Robert that it survives and thrives today; it would have disappeared had it not been for people like him. Robert and I subsequently served together on the board of Hearts football club. Everyone was really fond of him. We were robbed of his intense intellect, his passion for the club, and his companionship when MND took his life. He was respected and admired by all, and will be very sadly missed, especially by his wonderfully supportive family.

Gordon had a nickname when he worked at the Scottish Parliament. His nickname was “14%”. Many people may ask why that was. It was because when he worked as a researcher for the Scottish Labour party, he was responsible for 14% of all the freedom of information requests submitted to the Scottish Government. That fact was even mentioned by the former First Minister, the right hon. Member for Gordon (Alex Salmond), at First Minister’s Questions. The right hon. Gentleman was rather irritated by it. If Gordon is to leave any legacy, irritating the former First Minister is very high up in my book. Tonight, however, I want us to change Gordon’s nickname. I want us to change it from “14%” to “100%”, and we can do that by doubling the annual research budget for MND from £5 million to £10 million a year.

Gordon, in his death, transformed the lives of so many. The world is a better place for his having been in it. The understanding of MND is enhanced by his dedication to educating. The care of those suffering is enshrined in his having fought for it. The rights of those affected are secured because he demanded that. The cure for MND is closer after his fundraising for it. Gordon did so much in such a short space of time, and now it is our time to find a way to honour that legacy. I say this to the Minister: let us pledge tonight to be a little more like Gordon, and double the MND research budget.

In life, Gordon gave a voice to MND patients; in death, Gordon’s own voice speaks on. It speaks on in the words that he wrote, in the things that he achieved, and in the lives that he touched. I opened my speech in Gordon’s words, and I will finish with them, as echoed by the Scottish Labour leader Kezia Dugdale at his funeral on Saturday. Gordon said:

“What I have lost in strength of body, I make up for in strength of mind. I am more determined and driven than ever... I want to make every day count.

My love is deeper. I find joy in simpler things and in different places. I am more chilled out, at peace with the fact that there is so much in life that is out of our control.

Let’s celebrate the rich, diverse and complicated world we live in. Let’s savour each day. Let’s measure life not by length but by depth.”

Gordon Lewis Aikman, born on 2 April 1985, died on 2 February 2017, aged 31. May he rest in peace, but may his legacy live on.

Green Investment Bank

Ian Murray Excerpts

Wednesday 11th January 2017 Commons Chamber

[Mr Hurd]

There was a whole set of arrangements under which the special share solution was reached. It was debated through Parliament and settled through that process. My personal view is that it is a robust mechanism in itself, given its legal underpinning and the integrity and independence of the people selected to be the trustees and guardians of the process. I also come back to the fundamental point about the motivation of people who might want to buy this organisation, and the lens, criteria and disciplines we will have in evaluating their proposals and deciding whether or not to go ahead.

[Ian Murray (Edinburgh South) (Lab)]

I, along with many colleagues, fought for the headquarters of the GIB to come to Edinburgh, where it now has more than 50 staff. Can the Minister tell us how many of those 50 staff will remain in Edinburgh after privatisation?

Many people have mentioned Vince Cable, but the legacy of Vince Cable as Business Secretary is the botched privatisation of Royal Mail, and that is why people have concerns about the GIB. The reason why we have concerns about the sale of assets is that by its nature the GIB invests in projects that the market will not touch, and therefore when those projects come on-stream they are much more profitable than normal projects, and if a preferred bidder then sells them off, they will sell them at great profit at the taxpayer’s expense.

[Mr Hurd]

I recognise the importance of the GIB to Edinburgh and have agreed to meet with the Members of Parliament for that area to discuss this process. It was entirely the right decision to locate part of the organisation there, and jobs are a part of what we want to hear from bidders; we want to hear about commitment to staff and the ongoing organisation.

As the hon. Gentleman has mentioned staff, let me place on record—I hope this is shared by Members across the House—the Government’s admiration and respect for the senior management team and all staff at the GIB, led by Lord Smith and Shaun Kingsbury, not just for what they have achieved in a relatively short period, but for the professionalism with which they have conducted themselves during this process.

Exiting the EU: Science and Research

Ian Murray Excerpts

Monday 19th December 2016 Commons Chamber

[The Minister for Universities, Science, Research and Innovation (Joseph Johnson)]

I beg to move,

That this House has considered exiting the EU and science and research.

I am pleased to introduce today’s debate about science and research, which is one of a number of debates about our exit from the European Union. It is important that we continue to give Members of this House the opportunity to discuss and debate Brexit and the impact it will have on our country.

I would like to say up front that the UK’s science base is not only one of this country’s most impressive national achievements, but one of the strongest in the world. Within the G7, we have the most productive science base in terms of papers and citations per unit of GDP. With our world-class universities, four of which are in the world’s top 10, and 18 in the world’s top 100, we have a long-established system that supports and attracts the brightest minds throughout their career and enables them to generate high-quality research. With less than 1% of the global population and just over 3% of global research and development spend, the UK produces almost one fifth of the most highly cited research articles.

The benefits for our economy are very real. The World Economic Forum ranks the UK among the top four nations in the world for university-industry collaboration in R and D, and we ranked third in the global innovation index in 2016.

If hon. Members want a specific example, they might look at the space sector—a high-growth, high-productivity industry that showcases UK research strengths in a global market. Earlier this month at the European Space Agency Council of Ministers, the Government showed their confidence by investing an extra £1.4 billion in ESA, so that we support the world-class science and innovation underpinning this high-growth sector of the economy. Our investment of €170 million in the exploration programme will bring tangible benefits, ensuring, for example, that the ExoMars rover, which is being built in Stevenage is completed and launched.

Thanks to our investments we now lead the research and innovation programmes in ESA for telecoms, Earth observation and navigation, thereby positioning the UK to seize opportunities in those growing markets. I also signed a new memorandum of understanding with ESA to ensure that its European centre for space applications and telecommunications at Harwell, which is a fast-growing space cluster in Oxfordshire, is the focus for the agency’s commercial exploitation of space data.

Those and earlier investments are delivering results. The space sector in this country is growing strongly. It is now worth £13.7 billion a year to the UK economy, employing just under 40,000 people, and we are ambitious for it. We want to increase our share in the global sector to 10% by 2030, creating 100,000 new jobs.

Space is one of a number of success stories that are in part due to Government investments in collaborative structures with international partners in Europe and around the world—a story that we plan to continue writing long after we have left the European Union.

[Ian Murray (Edinburgh South) (Lab)]

The Minister has mentioned collaboration with EU partners and others around the world. I represent a university that has given us Dolly the sheep and, indeed, Higgs boson, so we know that collaboration works, but the only reason that Dolly the sheep and Higgs boson are associated with the University of Edinburgh is that it was able to lead those collaborative projects. We are hearing already that the prospect of leading such collaborative projects is being jeopardised, because of the decision to leave the European Union. Will the Minister do all that he possibly can to ensure that universities such as Edinburgh in my constituency are protected in our exiting the European Union?

[Joseph Johnson]

The hon. Gentleman makes an important point. That is why the Government have, in various announcements, given assurances to UK institutions and institutions across the European Union that we remain full members of the European Union and that we are eligible to lead European bids and to compete successfully in bids for funding streams. We continue to do so and we want institutions such as that which the hon. Gentleman represents in Edinburgh to continue to be as successful as they have been in the past.

This Government recognise that our world-leading science and research must be at the very heart of our industrial strategy, and we are matching rhetoric with resources. At the autumn statement, the Chancellor announced an additional £2 billion a year for R and D by 2021. That is the single biggest uplift in research and innovation spending in decades and it is an opportunity for us to make Britain, in the Prime Minister’s words, the

“global go-to place for scientists, innovators and tech investors”.

Exiting the EU: Higher Education

Ian Murray Excerpts

Wednesday 23rd November 2016 Westminster Hall

[Ian Murray (Edinburgh South) (Lab)]

It is a pleasure to serve for the first time under your chairmanship, Mr Davies. I pay tribute to my hon. Friend the Member for Ealing Central and Acton (Dr Huq) for securing this debate. If the tactic of flattering the Minister brings answers, we are all going to have to start being slightly nicer to Government Ministers. I wait with bated breath to see if the tactic works.

This is an incredibly important debate. Most of the issues being discussed will be repetitive, because we all represent university cities and are concerned about the impact of Brexit on what is happening in our universities. It is not just Opposition politicians who are concerned—vice-chancellors, principals, students, student bodies, academic staff and those involved in research are constantly knocking on our doors at advice sessions. They are watching debates such as this one, and want their questions answered, not just for their own personal needs, such as their academic careers or their passion for higher education and research, but for the wider higher education sector and the economy. We should bear that in mind. I hope the Minister will tell the Secretary of State for Exiting the European Union how important it is that he has a seat at the table to champion the cause of higher education in this debate.

In the short time available, I want to concentrate on Edinburgh University. It is in the heart of my constituency and epitomises the issues being discussed around the country, such as in Oxford, Cambridge or Loughborough, or in the west of Scotland, as we have just heard from the hon. Member for Paisley and Renfrewshire North (Gavin Newlands).

Edinburgh University is unique. It is one of the world’s top universities and 25% of its academic staff are from the European Union. That is higher than the average of 21% for Russell Group universities or 15% for universities across the UK as a whole. Some 14% of all students at Edinburgh University are from the EU, almost 5,000 in the last academic year, which is double the average for Russell Group universities. The figure is only 5% for universities across the UK. Some 10% of Edinburgh University’s entire total research income of £226 million in 2015 came from EU sources, with the largest proportion going to research in the College of Science and Engineering, the driver of innovation for the future needs of our country and economy. Figures up to February 2016 ranked Edinburgh University as the most successful Scottish higher education institution for Horizon 2020 funding, ranking sixth across the EU, gaining nearly €60 million in funding to date.

I hope the Minister realises how concerned we all are about Brexit and its impact on not just EU nationals but research funding and, critically, collaboration. Some 30% of the entire output of research from Edinburgh University, one of the world’s key research institutions, is from EU collaboration, co-authoring with other EU nation states. Anecdotal evidence, and some factual evidence that we have heard from my hon. Friends this morning, tells us that universities in the UK are still involved in those collaborative projects, but they are being told not to take the lead, not necessarily because of their skills or what they can bring to those projects, but because of the uncertainty about the impact that leaving the European Union will have on the projects. The Government have to reflect on that point seriously. Having universities in this country that are at the cutting edge of technology, research and development but which are unable to take the lead in big co-authored projects across the European Union diminishes our ability to run other major projects in the future and diminishes our higher education and research sector. To put the 30% into context, the figure is only 18% for co-authoring with the United States; collaboration with the EU is almost double, and that is why it is incredibly important.

I will not rehearse the arguments that my colleagues have already made, but I will re-emphasise the points that we need addressed. We need to maintain UK university access to EU research programmes. We need to seek income, partnerships and influence and make sure that outputs are collaborative, with UK universities right at the top of those collaborations. We need to continue UK contribution and access to EU research infrastructure, such as CERN. We need to preserve research excellence across the university sector. We need EU nationals to be told that they can stay and continue to work here. We need to continue to make sure that free movement, both EU and non-EU, is prioritised for our university sector, so that it can attract the very best, very highly skilled researchers. We need early clarity over the rules that will apply to tuition fees at Scottish, UK and EU level, so that we can make sure that future funding for universities is secure. We need continued access to Erasmus schemes. That is what universities are telling us they want. The Government have to deliver.

--- Later in debate ---

[Joseph Johnson]

In her party conference speech, the Home Secretary announced that she was conducting a review and would be consulting on arrangements for non-European economic area migration, including the study route. The process leading up to that consultation is still under way.

[Ian Murray]

What representations has the Minister made to the Home Office and the Prime Minister to try to win the argument that we should be taking students out of the immigration numbers to resolve all these issues?

[Joseph Johnson]

It is important for hon. Members to recognise that we already have a strong offer. We are second in the world after only the US in terms of the number of international students who come to study in this country—according to Home Office figures, the number of students coming here has risen by 14% since 2010—and we continue to be successful in attracting international students. We should not create an impression that we have closed off as a country, because that is clearly not borne out by the facts. It is not borne out by the successful recruitment of many institutions in this country. I would not want to create an impression that we were closed, because we are not; we welcome international students and we want to continue to do so.

As I said, the quality of the staff at our institutions is central to the UK’s outperformance, and we want them to feel welcome and that the Government appreciate their contributions to our institutions. We want to give them the assurances that they need to feel confident that they can continue to embed the richness that they bring to our institutions.

We also derive benefits from EU students. Hon. Members have referred several times to the contribution that EU students make to our institutions’ health. We want those students to continue to study here. We are extraordinarily successful in that respect. In 2013, 20% of EU students who chose to study overseas chose the UK—the greatest proportion of any country. We also welcome those who choose to study for a short time under the Erasmus programme. The hon. Member for Sheffield Central (Paul Blomfield) asked what the Government’s plans were for future involvement with Erasmus. Post-exit access to Erasmus will be a matter for the negotiations that he knows will follow the triggering of article 50. We will work through the implications for future years as part of those wider negotiations.

I completely share the determination of the hon. Members for Ealing Central and Acton and for Glasgow North West (Carol Monaghan)—and I underscore the Government’s absolute determination—to show that we are welcoming and will not tolerate hate crimes of any sort in our universities or our country. Since the referendum, the Government have worked closely with the police to monitor hate crime and ensure that local forces have the necessary assistance and guidance to respond, and police forces are responding robustly to incidents. Ministers and officials have also met ambassadors and high commissioners from EU states and offered them reassurance and a single point of contact to raise concerns on behalf of their citizens.

In the remaining minute or so, I will skip forward to deal with the points that were raised about research, which is clearly of great importance. My hon. Friend the Member for Harwich and North Essex (Mr Jenkin) and the hon. Member for Sheffield Central asked what relationship we will have with future Horizon 2020 programmes. The short answer is that it is too early to speculate about the UK’s future relationship with those programmes. There are already several models for co-operation by non-EU countries on research with the EU and EU member states, and there may be areas where the benefits of collaboration to both sides provide a case for ongoing co-operation. Again, that will be a matter for the negotiations about our future relationship. We are keenly aware that the matter is of great importance to the university sector, and it is fully represented in the thinking of the Cabinet Committee on Brexit, on which the Secretary of State for Business, Energy and Industrial Strategy sits.

Motion lapsed (Standing Order No. 10(6)).